Prognostic factors of recovery with medication in patients with taste disorders.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 33001974.
- Also identified by DOI 10.1371/journal.pone.0237270 and PMC identifier 7529239.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We aimed to elucidate the prognostic factors of the patients with taste disorders who were treated with popular and common medication in Japan. A retrospective study on the medical charts of a total of 255 patients with taste disorders who were treated primarily with oral medication including a zinc agent. The factors below were significantly linked with poor prognosis: 1) male gender, 2) taste disorders that began 3 months before starting treatment and 3) a severe taste disorder grade at the initial visit. We have concluded that the prognosis for the patients with taste disorders who were treated by popular and standard medication therapy in Japan recently was significantly linked to gender, the period of 3 months before starting the treatment and the severity of the disorder at the time of diagnosis. In addition, we recognized some limitations we should resolve in further research including a method of measuring "umami" and so on. Better awareness of these factors should be clinically useful when we manage patients with taste disorders. Earlier treatment should be started to cure the symptoms.
Medical subject headings
- Carnosine
- Organometallic Compounds
- Taste Disorders